• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Get a Comprehensive Insight into the National Sales of the Pharmaceutical Market in Canada

Posted on: Friday, 4 April 2008, 09:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c87749) has announced the addition of "IMS World Review Country Profile -- Canada" to their offering.

IMS Health's Country Profiles provide a comprehensive insight into the national sales of the pharmaceutical market in selected countries over 5 years. Each individual IMS Company Profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company's business strategy. Sales performance is analysed in terms of geographic region, major corporations, therapeutic classes, major products and new product activity.

All data is available over a 5 year period for easy trend analysis and is based on Quarter 4 sales figures.

Products mentioned:

- ALTACE

- CRESTOR

- EFFEXOR XR

- EPREX

- LIPITOR

- LOSEC

- NORVASC

- PANTOLOC

- PLAVIX

- ZYPREXA

Companies Mentioned:

- Pfizer

- Astrazeneca

- Apotex Inc

- Glaxosmithkline

- Janssen-Ortho Inc

- Sanofi-Aventis

- Novartis Pharma

- Roche

- Lilly

- Wyeth Pharmaceutic

- Novopharm

- Schering Health Ca

- Amgen

- Genpharm Pharm

- Ratiopharm

- Bms-Sanofi

- Bayer Pharma

- Abbott Pcd

- Altana Pharma Inc

- Boehringer Ing

- Ms&D

- Pharmascience

- Pfizer Consumer Hc

- Frosst

- Purdue Pharma

- Wyeth Cons Hc

- P&G Pharma

- Sandoz Canada Inc

- Bms Pharma

- Mcneil Consumer

- Lifescan

- Novo Nordisk Cda

- Berlex Canada

- Roche Diagnostics

- Abbott Spd

For more information, visit http://www.researchandmarkets.com/reports/c87749

Source: Business Wire

More News in this Category